TENORETIC SUMMARY
TENORETIC
(atenolol and chlorthalidone)
TENORETIC® (atenolol and chlorthalidone) is for the treatment of hypertension. It combines the antihypertensive activity of two agents: a beta1-selective (cardioselective) hydrophilic blocking agent (atenolol, TENORMIN®) and a monosulfonamyl diuretic (chlorthalidone).
TENORETIC is indicated in the treatment of hypertension. This fixed dose combination drug is not indicated for initial therapy of hypertension. If the fixed dose combination represents the dose appropriate to the individual patient's needs, it may be more convenient than the separate components.
|
NEWS HIGHLIGHTSMedia Articles Related to Tenoretic (Atenolol / Chlorthalidone)
Hypertension Drug Tekamlo (Aliskiren And Amlodipine) Approved By FDA
Source: Hypertension News From Medical News Today [2010.08.28]
Novartis' single pill combination of aliskiren and amlopidine - Tekamlo - has been approved by the Food and Drug Administration (FDA) for the treatment of hypertension. Data revealed that Tekamlo significantly reduced blood pressure compared to amlodipine or aliskiren (Tekturna) alone. The medication has been approved in tablet form...
Novel Combo Pill for Hypertension Approved
Source: MedPage Today Nephrology [2010.08.27]
(MedPage Today) -- Another type of combination pill for hypertension has won FDA approval -- this time putting a direct renin inhibitor together with a calcium channel blocker.
NICE Guideline To Drive Down A Leading Cause Of Maternal Death - Hypertension In Pregnancy
Source: Hypertension News From Medical News Today [2010.08.26]
A small amount of aspirin a day could help certain groups of pregnant women keep a potentially serious and sometimes fatal condition at bay. The National Institute for Health and Clinical Excellence (NICE) says this is just one of a number of ways to help prevent and treat hypertension (high blood pressure) before, during and after pregnancy...
In Some Patients, Hypertension Meds Raise Blood Pressure
Source: MedicineNet High Blood Pressure Specialty [2010.08.26]
Title: In Some Patients, Hypertension Meds Raise Blood Pressure
Category: Health News
Created: 8/25/2010 4:10:00 PM
Last Editorial Review: 8/26/2010
Blood Pressure Increased By Common Hypertension Drugs In Certain Patients
Source: Hypertension News From Medical News Today [2010.08.20]
Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect - raising blood pressure in a statistically significant percentage of patients...
Published Studies Related to Tenoretic (Atenolol / Chlorthalidone)
[A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice] [1990.04.09]
Two hundred and ninety-two hypertensive patients from general practice who had previously been treated with a diuretic with insufficient effect participated in a randomised trial for a period of three months. A total of 115 patients completed treatment with 50 mg atenolol (Tanormin) and 121 were treated with the combined preparation consisting of 50 mg atenolol and 12.5 mg chlothalidone (Tenoretic Mite) while 56 patients defected from the trial.
Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. [1990.03]
The antihypertensive effect of a fixed dosage combination of the cardioselective beta-adrenoceptor blocker, atenolol, and the oral thiazide-like diuretic, chlorthalidone (Tenoretic) was studied in 24 hypertensive Nigerians in a double-blind, cross-over comparison with three other treatments... The drugs were well tolerated.
Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison. [1988.11]
In a randomized, double-blind, parallel-group study of 31 patients with mild to moderate hypertension, we compared a placebo regimen with a regimen of atenolol and chlorthalidone (Tenoretic). The study, which lasted seven weeks, began with a single-blind two-week placebo lead-in period, followed by a four-week double-blind treatment phase, and concluded with a one-week single-blind placebo washout period.
[Photoallergy to Neotri and cross reaction to tenoretic--detection by systemic photoprovocation] [1988.01]
A patient is presented who suffered for 3 years from increasing photosensitivity with chronic eczematous lesions in sun-exposed areas...
|
